185
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Smokeless tobacco induces toxicity and apoptosis in neuronal cells: a mechanistic evaluation

ORCID Icon, , ORCID Icon, , , & ORCID Icon show all
Pages 477-496 | Received 18 Oct 2019, Accepted 02 Jul 2020, Published online: 26 Aug 2020
 

Abstract

Smokeless tobacco (SLT) or chewing tobacco has been a highly addictive practice in India across ages, posing major threat to the systemic health and possibly neurodegeneration. Earlier studies showed components of SLT could be harmful to neuronal health. However, mechanism of SLT in neurodegeneration remained unexplored. This study investigated the detrimental role of SLT on differentiated neuronal cell lines, PC12 and SH-SY5Y by using graded doses of water soluble lyophilised SLT. Reduced cell viability, compromised mitochondrial structure and functions were observed when neuronal cell lines were treated with SLT (6 mg/mL) for 24 h. There was reduction of oxidative phosphorylation and aerobic glycolysis as determined by diminution of ATP production (2.5X) and basal respiration (1.9X). Mitochondrial membrane potential was dropped by 3.5 times. Bid, a pro-apoptotic Bcl-2 family protein, has imperative role in regulating mitochondrial outer membrane permeabilization and subsequent cytochrome c release leading to apoptosis. This article for the first time indicated the involvement of Bid in SLT mediated neurotoxicity and possibly neurodegeneration. SLT treatment enhanced expression of cleaved-Bid in time dependent manner. The involvement of Bid was further confirmed by using Bid specific shRNA which reversed the effects of SLT and conferred significant protection from apoptosis up to 72 h. Thus, our results clearly indicated that SLT induced neuronal cell death occurred via production of ROS, alteration of mitochondrial morphology, membrane potential and oxidative phosphorylation, inactivation of survival pathway and activation of apoptotic markers mediated by Bid. Therefore, Bid could be a potential future therapeutic target for SLT induced neurodegeneration.

Acknowledgements

Professor Sanjit Dey acknowledges Centre for Research in Nanoscience and Nanotechnology, University of Calcutta and UGC-DAE, Kolkata Centre for providing research facilities. Authors gratefully acknowledge Dr. Soumitra Sinha Roy, Clinical Associate, Lung Transplant Unit, Toronto General Hospital, University Health Network, Toronto, Canada for his generous help in correcting the revised manuscript and Mr. Suvam Dey for providing certain editorial assistance.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Correction Statement

This article has been republished with minor changes. These changes do not impact the academic content of the article.

Additional information

Funding

A Research Fellowship from Indian Council of Medical Research (ICMR) [Ref. 5/3/8/43/ITR-F/ 2018-ITR; Dated: 15/05/2018], Government of India, University Research Fellowship- University Grant Commission (URF-UGC) [UGC/486/Fellow (Univ.)] and National Tea Research Foundation (NTRF) to S.B. are gratefully acknowledged. Prof. S.D. acknowledges the support of funding by NTRF under grant [17(264)/2011/3329], LSRB under grant [DLS/81/48222/LSRB-244/SH&DD/2012], CSIR under grant [23(0024)/12/EMR-II], Coconut Development Board under grant [1345/20011-Tech] and West Bengal DBT under grant [593-BT(Estt)/RD-9/11]; and UGC, Government India for support under CPEPA scheme granted [F. No. 8-2/2008(NS/PE)].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.